Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses how dysfunction in keratinocyte adhesion affects skin integrity and conditions like alopecia and keratoderma, highlighting the roles of intercellular junctions, and reports no new clinical results.

This abstract highlights hair loss in women as often misunderstood and lacking sympathy from others, without reporting additional clinical findings.

This study found that 49% of female breast cancer patients treated with CDK4/6 inhibitors for at least three months developed alopecia, which significantly impacted their quality of life, with greater alopecia severity leading to worse emotional and functional well-being.

This article discusses the challenges of treating androgenetic alopecia due to limited approved medications, potential side effects, and unmet expectations and reports no new clinical results.

This report describes five cases where sudden akathisia occurred in female patients with bipolar disorder after a ziprasidone dose reduction, emphasizing potential unexpected side effects of second-generation antipsychotics.

In this study, researchers found that alopecia significantly impacts depression and quality of life, especially for those with hereditary baldness in the Eastern Province of Saudi Arabia, and emphasized the need for psychological support to improve mental health.

This study suggests that mitochondrial dysfunction might contribute to the pathogenesis of Lichen planopilaris by triggering a metabolic shift that leads to chronic inflammation and hair follicle damage.

This review explores the psychological impact of chronic hair diseases, highlighting that the effects on self-confidence and quality of life are influenced by individual coping skills and personality traits, and notes the psychiatric comorbidities associated with conditions like alopecia.

This study found that among female patients with acute telogen effluvium, 83.7% reported either partial or complete resolution of hair shedding after three months of treatment including vitamin E and zinc supplements.

This study found that patients with telogen effluvium had a higher quality of life score compared to controls, despite no significant difference in self-esteem.

This case report describes a patient with complete androgen insensitivity syndrome experiencing female pattern hair loss, suggesting that factors beyond direct androgen action may contribute to this condition in women.

In this report, a 1-year-old boy with congenital atrichia with papular lesions was found to have a complete absence of scalp and body hair and keratin-filled cysts due to a mutation in the hairless gene.

Significant hair regrowth doesn't always mean complete hair recovery in alopecia areata.

In this study, finasteride 1 mg/day for 12 months did not improve hair growth or slow hair thinning in postmenopausal women with androgenetic alopecia compared to placebo.

This article discusses therapeutic options for androgenetic alopecia, emphasizing the importance of aligning treatments with patient preferences, but it reports no new clinical findings.

This case report discusses chronic mucocutaneous candidiasis with autoimmune and immune deficiencies in candidiasis-endocrinopathy syndrome, noting associated alopecia areata, ineffective topical immunotherapy, and asplenia.

In this study, researchers assessed the quality of life in 70 patients with alopecia areata, finding that treatment choice and age positively correlated with quality of life, while factors like sex, education, and knowledge did not.

This cross-sectional survey found that individuals with alopecia areata and androgenetic alopecia perceived stigmatization and impaired quality of life, with greater stigma reported in German-speaking participants; factors like gender, age, and disease severity influenced stigmatization levels.

This abstract does not provide a study or results, instead presenting a medical case involving a 26-year-old male with a shunt.

In this study, both alopecia areata and androgenetic alopecia were found to moderately impact quality of life, affecting emotional and social aspects in patients.

Micronutrient deficiencies might contribute to alopecia areata.

This review examines the complex relationship between hair loss, particularly in alopecia areata, and psychological/psychiatric conditions, concluding that stress and emotional factors frequently contribute to hair loss or alter treatment choices; it reports no new results.

This study examined women's experiences with baldness due to conditions like alopecia and monilethrix, highlighting how they navigate femininity and societal assumptions about illness.

In this study, researchers found that patients with severe alopecia areata often experience reduced health-related quality of life, with significant levels of anxiety and depression, and these mental health impacts may correlate with the severity of their condition.

This review discusses the need for a comprehensive treatment approach to alopecia, highlighting the limitations of pharmacological treatments and the lack of research on psychological interventions, but reports no new clinical results.

In this study, researchers reported that individuals with post-COVID-19 alopecia experienced a significant impact on their quality of life, particularly in the vitality domain, when compared to those without alopecia.

This study explores how children perceive peers with alopecia areata and the social effects associated with the condition, but it reports no new experimental findings.

This study found that children with alopecia areata had more neglectful family environments and higher levels of anxiety and depression compared to healthy control peers, suggesting a psychosomatic component to the condition.

This study found that patients with unresectable melanoma treated with AZD6244 experienced skin reactions, including depigmentation and papulopustular rashes, in patterns similar to those caused by EGFR inhibitors.

This study observed that depression and anxiety notably affect quality of life for patients with systemic lupus erythematosus, especially among African-American and Hispanic individuals who report higher unmet psychological needs.